TriPath Withdraws Its Second PMA Supplement Application This Year

TriPath Imaging has been reorganizing its clinical and regulatory affairs operations to prevent the continuation of problems that caused it to withdraw two separate PMA supplements so far this year

More from Archive

More from Medtech Insight